Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses

References

• GrossmanDLeffellDJThe molecular basis of nonmelanoma skin cancerArch Dermatol199713310126312709382565
   PubMedGoogle Scholar
• CriscioneVDWeinstockMANaylorMFActinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention TrialCancer2009115112523253019382202
   PubMed Web of Science ®Google Scholar
• BuckHWImiquimod (Aldara cream)Infect Dis Obstet Gynecol19986249519702584
   PubMedGoogle Scholar
• HemmiHKaishoTTakeuchiOSmall anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathwayNat Immunol20023219620011812998
   PubMed Web of Science ®Google Scholar
• MillerRLGersterJFOwensMLImiquimod applied topically: A novel immune response modifier and new class of drugInt J Immunopharmacol1999211111410411278
   PubMed Web of Science ®Google Scholar
• OwensMLBridsonWESmithSLMyersJAFoxTLWellsTMPercutaneous penetration of Aldara™ cream, 5% during the topical treatment of genital and perianal wartsPoster presented at the 46th annual clinical meeting of the American College of Obstetricians and GynecologistsNew Orleans, LAMay 9–13, 1998
   Google Scholar
• TygumKISmithSLMyersJAPercutaneous penetration of [14C]-imiquimod from a single application of creamPharm Res.1995129 Suppl Abstr 7339.
   Google Scholar
• KulpJLevySFeinMCAdamsMFurstJMengTCPharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalpArch Dermatol Res2010302753954420204654
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationBioequivalence of generic imiquimod cream, 5% when compared to Aldara™ (imiquimod) cream, 5% in the treatment of actinic keratosis Clinicaltrials.gov Identifier: NCT00948428. Available at: http://clinicaltrials.gov/ct2/show/NCT00948428. Accessed March 22, 2011.
   Google Scholar
• EdwardsLOwensMLAndresKLA pilot study evaluating imiquimod 5% cream versus vehicle in the treatment of actinic keratosesPoster presented at the 58th annual meeting of the American Academy of DermatologySan Francisco, CAMarch 10–15, 2000
   Google Scholar
• StockflethEMeyerTBenninghoffBChristophersESuccessful treatment of actinic keratosis with imiquimod cream 5%: A report of six casesBr J Dermatol200114451050105311359396
   PubMed Web of Science ®Google Scholar
• PersaudANShamuelovaEShererDClinical effect of imiquimod 5% cream in the treatment of actinic keratosisJ Am Acad Dermatol200247455355612271300
   PubMed Web of Science ®Google Scholar
• SalascheSJLevineNMorrisonLCycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trialJ Am Acad Dermatol200247457157712271303
   PubMed Web of Science ®Google Scholar
• LebwohlMDinehartSWhitingDImiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsJ Am Acad Dermatol200450571472115097955
   PubMed Web of Science ®Google Scholar
• SzeimiesRMGerritsenMJGuptaGImiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histologyJ Am Acad Dermatol200451454755515389189
   PubMed Web of Science ®Google Scholar
• KormanNMoyRLingMDosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: Results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trialsArch Dermatol2005141446747315837864
   PubMedGoogle Scholar
• LeePKHarwellWBLovenKHLong-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% creamDermatol Surg200531665966415996416
   PubMed Web of Science ®Google Scholar
• GuptaAKDaveyVMcPhailHEvaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studiesJ Cutan Med Surg20059520921416502198
   PubMed Web of Science ®Google Scholar
• TanghettiEWerschlerPComparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalpJ Drugs Dermatol20076214414717373172
   PubMedGoogle Scholar
• KrawtchenkoNRoewert-HuberJUlrichMMannISterryWStockflethEA randomised study of topical 5% imiquimod vs topical 5-fluorouracil vs cryosurgery in immunocompetent patients with actinic keratoses: A comparison of clinical and histological outcomes including 1-year follow-upBr J Dermatol2007157Suppl 2344018067630
   PubMed Web of Science ®Google Scholar
• StockflethESterryWCarey-YardMBichelJMulticentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the headBr J Dermatol2007157Suppl 2414618067631
   PubMed Web of Science ®Google Scholar
• SwansonNAbramovitsWBermanBKulpJRigelDSLevySImiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cyclesJ Am Acad Dermatol201062458259020133013
   PubMed Web of Science ®Google Scholar
• HankeCWBeerKRStockflethEWuJRosenTLevySImiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cyclesJ Am Acad Dermatol201062457358120133012
   PubMed Web of Science ®Google Scholar
• TanJKThomasDRPoulinYMaddinFTangJEfficacy of imiquimod as an adjunct to cryotherapy for actinic keratosesJ Cutan Med Surg200711619520118042331
   PubMed Web of Science ®Google Scholar
• JorizzoJLMarkowitzOLebwohlMGA randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratosesJ Drugs Dermatol2010991101110820865842
   PubMed Web of Science ®Google Scholar
• ShaffelburgMTreatment of actinic keratoses with sequential use of photodynamic therapy and imiquimod 5% creamJ Drugs Dermatol200981353919180894
   PubMed Web of Science ®Google Scholar
• UlrichCBuschJOMeyerTSuccessful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: A report of six casesBr J Dermatol2006155245145416882188
   PubMed Web of Science ®Google Scholar
• Ben M’barekLMebazaaAEuvrardS5% topical imiquimod tolerance in transplant recipientsDermatology2007215213013317684375
   PubMed Web of Science ®Google Scholar
• UlrichCBichelJEuvrardSTopical immunomodulation under systemic immunosuppression: Results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patientsBr J Dermatol2007157Suppl 2253118067628
   PubMed Web of Science ®Google Scholar
• O’MahoneyCLawCGollnickHPMMariniMNew patient-applied therapy for anogenital warts is rated favourably by patientsInt J STD AIDS20011256557011516364
   PubMed Web of Science ®Google Scholar
• SkinnerRRole of topical therapies in the management of cutaneous diseaseJ Cutan Med Surg20048Suppl 3223115647859
   PubMed Web of Science ®Google Scholar
• BensonEImiquimod: Potential risk of an immunostimulantAustralas J Dermatol200445212312415068461
   PubMedGoogle Scholar
• LinRLaddDJPowellDJWayBVLocalized pemphigus foliaceous induced by topical imiquimodArch Dermatol200414088989015262711
   PubMedGoogle Scholar
• FantiPADikaEVaccariSMiscialCVarottiCGeneralized psoriasis induced by topical treatment of actinic keratosis with imiquimodInt J Dermatol200645121464146517184267
   PubMed Web of Science ®Google Scholar
• GreenbergHLCohenJLRosenTOrengoISevere reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomesJ Drugs Dermatol20076445245817668546
   PubMedGoogle Scholar
• YangFCJessupCDahiyaMReynoldsRPityriasis rubra pilaris exacerbation with topical use of imiquimodInt J Dermatol200847101076107818986361
   PubMed Web of Science ®Google Scholar
• CondeJDavisKNtuenEBalmerNJonesDMcMichaelAA case of imiquimod-induced alopeciaJ Dermatolog Treat201021212212419488918
   PubMed Web of Science ®Google Scholar
• VaccaroMBarbuzzaOGuarneriBErosive pustular dermatosis of the scalp following treatment with topical imiquimod for actinic keratosisArch Dermatol2009145111340134119917978
   PubMedGoogle Scholar
• BurnettTJEnglishJC3rdFerrisLKDevelopment of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratosesJ Drugs Dermatol2010981022102420684157
   PubMed Web of Science ®Google Scholar
• GoldMHPharmacoeconomic analysis of the treatment of multiple actinic keratosesJ Drugs Dermatol200871232518246694
   PubMed Web of Science ®Google Scholar
• StockflethEChristophersEBenninghoffBSterryWLow incidence of new actinic keratoses after topical 5% imiquimod cream treatment: A long-term follow-up studyArch Dermatol2004140154215611446
   PubMed Web of Science ®Google Scholar